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Abstract There is considerable evidence that smoke
exposure during pregnancy (SDP) environmentally influ-
ences birth weight after controlling for genetic influences
and maternal characteristics. However, maternal smoking
during pregnancy—the behavior that leads to smoke
exposure during pregnancy—is also genetically-influenced,
indicating the potential role of passive gene-environment
correlation. An alternative to passive gene-SDP correlation
is a cascading effect whereby maternal and child genetic
influences are causally linked to prenatal exposures, which
then have an ‘environmental’ effect on the development of
the child’s biology and behavior. We describe and
demonstrate a conceptual framework for disentangling
passive rGE from this cascading GE effect using a sys-
tems-based polygenic scoring approach comprised of genes
shown to be important in the xenobiotic (substances for-
eign to the body) metabolism pathway. Data were drawn
from 5044 families from the Avon Longitudinal Study of
Parents and Children with information on maternal SDP,
birth weight, and genetic polymorphisms in the xenobiotic
pathway. Within a k-fold cross-validation approach
(k = 5), we created weighted maternal and child polygenic
scores using 18 polymorphisms from 10 genes that have
been implicated in the xenobiotic metabolism pathway.
Mothers and children shared variation in xenobiotic
metabolism genes. Amongst mothers who smoked during
pregnancy, neither maternal nor child xenobiotic metabo-
lism polygenic scores were associated with a higher like-
lihood of smoke exposure during pregnancy, or the severity
of smoke exposure during pregnancy (and therefore, nei-
ther proposed mechanism was supported), or with child
birth weight. SDP was consistently associated with lower
child birth weight controlling for the polygenic scores,
maternal educational attainment, social class, psychiatric
problems, and age. Limitations of the study design and the
potential of the framework using other designs are
discussed.
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Introduction
Smoke exposure during pregnancy (generally assessed via
maternal smoking during pregnancy) has been extensively
studied as an environmental teratogen which can adversely
affect child physical and behavioral development (e.g.,
Gaysina et al. 2013; Herrmann et al. 2008; Knopik 2009;
Kramer 1987; Milberger et al. 1996; Stone et al. 2014;
Ward et al. 2007). In recent years this association, partic-
ularly with behavioral outcomes, has been challenged by
researchers using genetically-informed approaches that
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have shown reductions in the strength of associations when
controlling for genetic influences (e.g., Agrawal et al.
2008; D’Onofrio et al. 2003; Gaysina et al. 2013; Knopik
2009; Rice et al. 2009; Thapar et al. 2003). Importantly,
associations of SDP with neurobiological and behavioral
outcomes later in development may be mediated by low
birth weight (Agrawal et al. 2010). Generally, SDP is
associated with about a 5 % reduction in birth weight (on
average * 150 g Kramer 1987; Kramer et al. 2001), fol-
lowing a dose response pattern, with more SDP resulting in
lower birth weight and with SDP later in pregnancy
exaggerating the effect. Low birth weight has been asso-
ciated with increased morbidity and mortality (McIntire
et al. 1999), and the link between low birth weight and
mortality appears stable (e.g., from 1997 to 2002) despite
advances in obstetric and neonatal health care (Fanaroff
et al. 2007). Here, we examine competing hypotheses for
how SDP is associated with low birth weight, as under-
standing potential causes and possible mechanisms of low
birth weight is imperative for improving mental and
physical health outcomes as well as reducing infant
mortality.
Smoke exposure during pregnancy may cause low birth
weight due to the environmental (intrauterine) impact of
nicotine and toxins in cigarette smoke on placental and
fetal development (e.g., as evidenced by animal models;
Ernst et al. 2001). However, if specific maternal and child
genetic variation or sets of genetic variants are associated
with SDP exposure, and mothers pass those variants (or
sets of variants) in addition to exposure to SDP to the child,
passive gene-environment correlation (rGE) may explain at
least part of this association. Much of the early research
examined zero-order associations without considering
possible confounding factors. More recently, genetically-
informed studies have examined whether SDP actually
exerts an environmental influence on child development
beyond the contributions of genetics and other maternal
characteristics. There is considerable evidence that SDP
does environmentally influence birth weight, although the
association may be attenuated after controlling for genetic
influences and other maternal characteristics (e.g., maternal
age, education, SES, etc.; Agrawal et al. 2010; D’Onofrio
et al. 2003; Jua´rez and Merlo 2013; Knopik et al. 2015b;
Rice et al. 2009). However, several quantitative genetic
study designs (e.g., children of twins) have also shown that
SDP is under genetic influence, indicating a potential role
of passive rGE (Agrawal et al. 2008; D’Onofrio et al.
2003). That is, maternal genes may confound the associa-
tion of SDP and birth weight via the likelihood of mothers
smoking, severity of mothers’ smoking, or via differential
metabolism of smoking byproducts that may influence
birth weight. In further support of the passive rGE pathway
is the finding that controlling for family influences reduces
the SDP-birth weight association, suggesting that this
relationship is partially confounded by maternal charac-
teristics or genetics (Jua´rez and Merlo 2013). In sum,
existing evidence is unclear as to whether and to what
extent the SDP-birth weight association may be a direct
environmental influence or confounded by passive rGE
(e.g., can be accounted for by genetic factors).
Whether SDP has a causal environmental effect on low
birth weight or whether the association arises via passive
rGE has important implications. For example, in general, if
SDP has a causal, environmental effect on low birth
weight, then SDP is a plausible target for interventions
aiming to reduce negative sequelae related to low birth
weight (e.g., later ADHD problems, infant mortality and
morbidity). However, if SDP is spuriously associated with
low birth weight, through a passive rGE, then intervention
efforts could be better spent on other plausibly causal tar-
gets during pregnancy (e.g., other teratogens, dietary
choices). Thus, in this study we present a new conceptual
framework for understanding whether SDP has a causal
environmental effect on low birth weight or whether the
association arises via passive rGE. This work complements
the existing literature using specialized genetically-in-
formed designs and attempts to further elucidate the
mechanisms of the association between SDP and birth
weight.
Mechanisms of genetic and SDP influences on child
outcomes
The possibility of passive rGE is particularly important to
investigate. As noted above, passive rGE occurs when
genetic variation that the parent and child share influences
both the environment provided by the parent and the out-
come of interest in the child. That is, passive rGE is a non-
causal explanation such that genetic influences shared by
the mother and child, which are also associated with the
exposure (SDP), explain the association of SDP and birth
weight. Thus, the association of interest (SDP and birth
weight) would be spurious, and instead SDP would be a
variable that represents genetic risk for birth weight. Thus,
if passive rGE is operating, it would be unlikely to uncover
a mechanism by which SDP influences birth weight
because of the confounding effect of genetic transmission;
a direct environmental mechanism would not drive the
association in this case. In contrast, genetic influences may
only partly confound the association; passive rGE may
explain a part of the association leaving a smaller role for
direct environmental mechanisms than would be concluded
from non-genetically informed studies. Of the various
quantitative genetic study designs, thus far, only children-
of-twins designs have been able to show that maternal
genetic influences are associated with her smoking during
pregnancy (e.g., D’Onofrio et al. 2003). These findings
provide evidence of possible (not definitive) passive rGE in
the association of SDP and child outcomes.
An alternative to passive gene-SDP correlation is a
cascading effect whereby genetic influences (some of
which the child is likely to inherit) are causally linked to
prenatal exposures, which then have an ‘environmental’
effect on the development of the child’s biology and
behavior. Importantly, this is a plausibly causal mecha-
nism, which includes genetic and environmental influences
unfolding in a temporal process through biologically based
mechanisms. It is possible to disentangle passive rGE from
the cascading effect described above using molecular
genetic data. The criteria for concluding passive rGE and a
cascading effect are presented in Fig. 1. For both passive
rGE and the cascade, two conditions must be met:
(a) mother and child must share the genetic variation of
interest, and (b) maternal genetic variation must be related
to SDP. For passive rGE to be occurring, (c) that same
genetic variation in the child must also be related to SDP.
However, this is not a necessary condition for a develop-
mental cascade, because there could be a teratogenic effect
of SDP independent from an association of child genetic
variation with SDP. A significant correlation of child
genetic variation and SDP does not necessarily rule out the
cascade effect because the association may only partly
account for relations of SDP and birth weight. That is, there
may still be environmental teratogenic effects of SDP on
birth weight that are either independent, or potentially
moderated by child genetic variation. The key difference
needed to understand whether passive rGE is occurring or
whether there is a potentially causal cascade including both
genetic and environment influences is found in (d) the
nature of the association of SDP with the child outcome, in
this case birth weight. If SDP is related to the outcome at
the zero-level only, but not after controlling for genetic
influences, then passive rGE is occurring. This is because a
key concept of rGE is that it describes genetic mediation of
environment-outcome associations (Plomin 2014). That is,
if genetics fully mediate the association, and therefore the
association is explained by passive rGE, then the associa-
tion would need to disappear when the relevant genes are
added to the model. However, if SDP is related to the
outcome even after controlling for genetic influences
(particularly Gc [child genetic influences], but also Gm
[maternal genetic influences], in Fig. 1), then there is
stronger evidence for a developmental GE cascade. That is,
the genetic confound is insufficient to fully explain the
association of SDP and birth weight, and so there could be
a biologically based mechanism by which SDP exposure
leads to lower birth weight.
The utility of molecular genetic data
As noted above, thus far, quantitative genetic designs have
been used to infer (in the case of children-of-twins studies)
or control for (in the case of adoption designs) passive rGE.
It is important to confirm findings from quantitative genetic
designs using other strategies in order to ensure that find-
ings do not arise from sampling techniques. In particular, it
is important to use measured genes (Plomin 2014) to
determine whether maternal genetic influences are associ-
ated with the amount of smoke exposure during pregnancy
experienced by the developing fetus. Examining measured
genes may better elucidate specific biologically-based
mechanisms by which SDP or potential passive gene-pre-
natal environment correlation contributes to child devel-
opment than quantitative genetic designs.
Molecular genetic data allows for better specificity than
is possible using latent factors to assess genetic influences
Fig. 1 Conceptual Model. For both passive rGE and a GE cascade,
a (mother and child share genetic variation) and b (maternal genetic
variation is related to the environmental measure) must be present.
The presence of a and b are equivalent to what has typically been
called passive rGE or possible passive rGE. A more conservative test
of passive rGE also requires c (child genetic variation shared with
maternal genetic variation correlated with the environmental
measure) to be present. If d (environmental measure associated with
outcome) is significant only at baseline, and not when also accounting
for the contributions of Gm (maternal genetic influences) and Gc
(child genetic influences), and a, b, and c are true, this is strong
evidence of passive rGE specific to the biological mechanism in
question. If d is significant after controlling for Gm and Gc, and a and
b are true, then the evidence is more supportive of a GE cascade
as in quantitative genetic studies. One commonly used
approach for creating and examining the polygenicity of
behavioral phenotypes involves a two-step approach. First,
a discovery sample is used to identify the gene variants
most highly correlated with the outcome of interest. Then,
a polygenic risk score is computed and tested in an inde-
pendent sample using those most relevant genes identified
in the discovery sample (e.g., Purcell et al. 2009; Salvatore
et al. 2014). However, when specific biological mecha-
nisms are of interest, theoretically and biologically-based
sets of genes can be grouped in order to index the genetic
variation underlying the specific biological pathway or
mechanism of interest (rather than empirically identifying
the most highly associated gene variants across the entire
genome). Thus far, systems-based genetic analyses have
been most frequently implemented using computed poly-
genic scores comprised of a set of genes carefully chosen to
characterize a specific biological mechanism (e.g., Der-
ringer et al. 2012; Juhasz et al. 2014). However, other
methods besides the computation of polygenic scores can
be used (e.g., Genome-Wide Complex Trait Analysis
(GCTA); Yang et al. 2011). Polygenic scores may be
particularly useful in the absence of complete genome-
wide data and in the case of smaller sample sizes, as there
is a single regression test of the polygenic score on the
outcome after the score is created, whereas GCTA requires
an extremely large sample in order to obtain enough
genetic variation across unrelated individuals to fit the
biometric models. The present study utilizes a systems-
based polygenic scoring approach for investigating the
possibility of a specific, identifiable passive rGE underly-
ing the association of maternal smoking during pregnancy
and child birth weight.
Xenobiotic metabolism genes
As an example of one plausible biological mechanism that
may represent passive rGE or a cascading effect of genes
and SDP for birth weight, we consider the role of xeno-
biotic metabolism genes. Maternal xenobiotic metabolism
genes help regulate the metabolism of teratogens. This
includes the metabolism of nicotine, but also many other
teratogens (e.g., pesticides, alcohol, other toxins). Thus,
maternal xenobiotic metabolism genes putatively have an
effect on the amount of nicotine (and other teratogens) that
will be available to cross the placenta and affect fetal
development. Further, maternal xenobiotic metabolism
genes are likely to also have an effect on the extent to
which mothers smoke, and their ability or desire to quit or
continue smoking during pregnancy. For example, some
genes implicated in the xenobiotic metabolism pathway
(e.g., CYP2A6) have been linked with smoking behavior
(Thorgeirsson et al. 2010), and some (e.g., in the alcohol
dehydrogenase family) have been selected for inclusion on
a chip designed to index genes associated with nicotine
dependence and other smoking phenotypes (http://bior
ealmresearch.com/smokescreen/). Thus, in the case of
genes in the xenobiotic metabolism pathways, we would
expect maternal genetic variation to be associated with the
extent to which children are exposed to maternal smoking
during pregnancy (e.g., path b in the conceptual model,
Fig. 1). Mothers are also likely to pass these genes related
to drug metabolism to the child, as mothers and children
share 50 % of their genes on average (e.g., path a in the
conceptual model, Fig. 1). Thus, child xenobiotic meta-
bolism genes make up the ‘third line of defense’ (after the
placenta; Blumenfeld et al. 2009) in the metabolism of
nicotine and will further have an effect on the amount of
nicotine and other smoke byproducts available to affect
fetal development1 (e.g., path c in Fig. 1).
Passive rGE
If maternal and child xenobiotic metabolism genes are
associated with SDP exposure (paths b and c in the con-
ceptual model, Fig. 1, respectively) and mothers pass the
genes in addition to the SDP exposure to the child (path a
in the conceptual model, Fig. 1), then passive rGE may
explain the association of SDP and birth weight. In the
literature, passive rGE is clearly defined as non-causal.
Thus far, because passive rGE has primarily been explored
using quantitative genetic designs, it is often considered in
broad terms. Here, we extend the broader concept of pas-
sive rGE to consider a specific example of a narrower,
biologically informed passive rGE. A spurious association
of SDP and birthweight, when xenobiotic metabolism
genes are implicated (e.g., there is a direct influence of
xenobiotic metabolism genes on birth weight rendering the
SDP-birthweight association spurious), is an example of a
specific passive rGE. That is, the SDP-birthweight asso-
ciation would not be a direct environmental influence but
rather explained by the action of xenobiotic metabolism
genes on birthweight even when mothers do not smoke
during pregnancy. Thus, for this specific passive rGE to
occur, xenobiotic metabolism genes must have a direct
influence on birth weight.
There is some evidence of this direct association in
candidate gene studies (e.g., Infante-Rivard et al. 2006;
Nukui et al. 2004) although recent GWAS studies of birth
weight have not found significant hits among xenobiotic
1 Xenobiotic metabolism genes may also be expressed in placental
tissue, which represents the second line of defense for the developing
child (Blumenfeld et al. Blumenfeld et al. 2009). However, here we
focus on maternal and child genetic variation only, as epigenetic
information from the placenta is needed to thoroughly investigate this
mechanism which is out of the scope of the current manuscript.
metabolism genes specifically (although it is unclear how
well xenobiotic genes were covered in the arrays used, or
whether there was sufficient exposure to manifest effects;
Freathy et al. 2010; Horikoshi et al. 2013). The mechanism
of action of xenobiotic metabolism genes does allow for
xenobiotic metabolism genes to have a direct influence on
birth weight. For example, genes in the glutathione
S-transferase family each play an important role in detox-
ification by coding for enzymes that catalyze the conju-
gation of reduced glutathione with a variety of hydrophobic
and electrophilic compounds. Deletions in the glutathione
S-transferase mu 1 (GSTM1) gene and from the glutathione
S-transferase theta 1 (GSTT1) gene (and especially both
risk alleles together) have been shown to be associated with
fetal growth restriction in infants exposed to organochlo-
rine pesticides (Sharma et al. 2012), and the GSTT1
deletion has been associated with small-for-gestational age,
especially among youth exposed to smoking during preg-
nancy (Infante-Rivard et al. 2006). Consuming more iron
during pregnancy was associated with higher birth weight
in infants without the GSTM1 deletion, even adjusting for a
host of maternal and fetal covariates, including urinary
cotinine levels (Hur et al. 2013). Thus, genes in the glu-
tathione S-transferase family are mechanistically linked to
birth weight through the ways in which exposures to
multiple teratogens are metabolized in both the mother and
child. These findings provide evidence that genes impli-
cated in the xenobiotic pathway may have direct effects on
birth weight, and further that their effects on birth weight
can be independent of smoking during pregnancy as a
specific teratogenic exposure.
In terms of passive rGE, SDP then may be an environ-
mental influence that is associated with xenobiotic meta-
bolism genes in the mother (e.g., associated with maternal
smoking behavior and her inability to quit smoking during
pregnancy), but not actually exert an influence on birth
weight if the direct association of these genes in the fetus
on birth weight is driven by the metabolism and level of
exposure of other teratogens experienced by the mother
and fetus (e.g., pesticides, dietary choices). These other
exposures may or may not be associated with SDP and are
infrequently measured and controlled in studies of SDP and
birth weight. Thus, it is possible that xenobiotic metabo-
lism genes have a more broad direct effect on birth weight,
which could render the more specific association of SDP
and birth weight spurious and therefore fall under the
mechanism of a specific passive rGE.
Developmental gene-environment cascade
Alternatively, the xenobiotic metabolism genes may
launch a cascade influencing (1) mothers’ ability or
inability to quit, subsequently exposing the child to SDP,
(2) mother’s and child’s ability to metabolize nicotine and
other smoke byproducts and therefore modifying the
extent of the child’s exposure to SDP, and (3) subse-
quently the association of SDP to birth weight. As noted
above, the key difference (if paths a, b, and c are present)
would be whether the association of SDP and birth weight
(path d in the conceptual model, Fig. 1) is significant after
controlling for the influence of maternal (path Gm in the
conceptual model, Fig. 1) and child (path Gc in the con-
ceptual model, Fig. 1) xenobiotic metabolism genes. This
gene-environment cascade mechanism is supported by
findings that the association of SDP and birth weight
remains robust even when controlling for genetic influ-
ences and other maternal characteristics (Agrawal et al.
2010; D’Onofrio et al. 2003; Jua´rez & Merlo 2013;
Knopik et al. 2015b; Rice et al. 2009).
Present study
The goal of the current study is to test whether there is a
passive gene-SDP correlation, or whether SDP-birth weight
associations represent a developmental gene-environment
cascade using a large cohort of mothers and their children.
We use a conservative systems-based approach in order to
ascertain whether genes from the maternal xenobiotic
pathway are associated with her smoking behavior during
pregnancy. We also test specifically for passive gene-SDP
associations by testing whether mothers and children share
xenobiotic metabolizing gene variation, and whether child
xenobiotic metabolizing genes are also associated with
SDP at the zero-order level, and after controlling for the
polygenic score indexing xenobiotic metabolism gene
variation and other maternal characteristics. Based on
previous literature, we expect that (a) mother and child will
share at least 50 % (expected for mother- to- child trans-
mission) of xenobiotic metabolizing gene variation, and
(b) that maternal gene variation will be related to SDP. We
were unable to hypothesize whether (c) child xenobiotic
metabolizing gene variation would be related to SDP.
However, we do expect that (d) associations of SDP and
birth weight would be present, even after controlling for
genetic influences. Because of hypothesis (d), overall we
expected results to be consistent with a cascade model
rather than passive rGE.
Method
Participants
Data were drawn from the Avon Longitudinal Study of
Parents and Children (ALSPAC; Boyd et al. 2013).
ALSPAC recruited 14,541 pregnant women resident in
Avon, UK with expected dates of delivery 1st April 1991 to
31st December 1992. The total sample represented 15,458
fetuses; 14,775 were live births and 14,701 were alive at
1 year of age. Ethical approval for the study was obtained
from the ALSPAC Ethics and Law Committee and the
Local (Rhode Island Hospital) Research Ethics Commit-
tees. We used only the portion of the live births for which
there was information on maternal smoking during preg-
nancy (N = 11,133), and birth weight (N = 13,901), and
had the relevant polymorphisms (see below) for mothers
(N = 7553) and children (N = 6754). For multiple births
(N = 406), we randomly chose only one twin for inclusion
in the analysis. This resulted in an analytic sample of 5044
families. Please see Boyd et al. (2013) for additional
sample and recruitment details.
Measures
Please note that the study website contains details of all the
data that is available through a fully searchable data dic-
tionary (http://www.bris.ac.uk/alspac/researchers/data-
access/data-dictionary/).
Xenobiotic metabolism genes
We used 18 polymorphisms from 10 genes that have been
implicated in the xenobiotic metabolism pathway (see
Table 1 for details). These included rs4986782 and
rs4987076 from NAT1, and rs1799930, rs1799931, and
rs1801280 from NAT2 within the N-acetyltransferase
family; rs1695 from GSTP1 and deletions from GSTM1
and GSTT1 within the glutathione S-transferase family;
rs284779 from ADH7, rs975833, rs1229966, and
rs2866151 from ADH1A, rs2066701 and rs4147536 from
ADH1B, and rs3762894, rs4148884, rs4699714 from
ADH4 within the alcohol dehydrogenase family;
rs28399433 from CY2A6_9 within cytochrome P450,
family 2, subfamily A. See Table 1 for more information
on the gene families, functions, as well as specific genes
and polymorphisms included here.
Smoking during pregnancy (SDP)
The quantity of cigarettes smoked on average per day
across the first 3 months of pregnancy was assessed via
self-report when mothers were 18 weeks pregnant. The
current number of cigarettes smoked per day was also
assessed via self-report when mothers were 32 weeks
pregnant. These variables were used to create a SDP
severity score theoretically consistent with research
showing dose–response patterns of exposure to nicotine
and low birth weight (Ernst et al. 2001). The severity score
was built on the following assumptions: (1) continuing to
smoke later in pregnancy represents a higher likelihood of
risk than successfully quitting in or shortly after the first
trimester; (2) smoking later in pregnancy imparts greater
risk than smoking earlier in pregnancy (in the rare instan-
ces where mothers begin to smoke after the first trimester;
e.g., Dwyer et al. 2009; Hebel et al. 1988); (3) smoking less
than a half pack per day, smoking between a half and
whole pack per day, and smoking more than a pack per day
represent qualitatively different levels of risk (McNeil
1995). As such, the severity score had 7 levels (see Knopik
et al. 2015a also in this Special Issue):
0 = no smoking during pregnancy in either the first
trimester or later in pregnancy (N = 8036)
1 = 1-10 cigarettes per day in the first trimester, no
smoking later in pregnancy (N = 473)
2 = 11-20 cigarettes per day in the first trimester, no
smoking later in pregnancy (N = 45)
3 = 21 ? cigarettes per day in the first trimester, no
smoking later in pregnancy (N = 33)
4 = any smoking later in pregnancy but not during the
first trimester (N = 169)
5 = 1-10 cigarettes per day later in pregnancy and any
smoking in the first trimester (N = 1289)
6 = 11-20 cigarettes per day later in pregnancy and any
smoking in the first trimester (N = 457)
7 = 21 ? cigarettes per day later in pregnancy and any
smoking in the first trimester (N = 343)
Birth weight
Birth weight was assessed from obstetric data, recorded by
the ALSPAC measurers, and via birth notification. We used
the ALSPAC preferred birth weight (detailed notation
available on the study website; http://www.bris.ac.uk/
alspac/researchers/data-access/data-dictionary/). Briefly, if
all birth weights from each data source were identical, that
was the preferred birth weight. In cases where the dis-
agreement across the different assessments was [100 g
birth weight was set to missing. In cases where the dis-
agreement across the different assessments was \100 g,
the lower birth weight was used.
Covariates
We included the following covariates: child sex and
maternal educational attainment, social class, psychiatric
problems, and age. Maternal educational attainment, social
class, psychiatric problems, and age were assessed when
mothers were 32 weeks pregnant. Social class is a standard
variable derived by the ALSPAC team comprised of
occupation information (e.g., occupation, industry, man-
agerial status). ‘Psychiatric problems’ is an indicator
variable denoting the absence/presence of any of the fol-
lowing: drug addiction, alcoholism, schizophrenia, anor-
exia nervosa, severe depression, and ‘‘other psychiatric
problem’’ either recently or in the past, assessed during
pregnancy. Detailed notation for each covariate is available
on the study website; http://www.bris.ac.uk/alspac/
researchers/data-access/data-dictionary/.
Analytic strategy
In order to test for criterion (a) we examined whether
mothers and children were concordant for the number of
minor alleles for each polymorphism. This was opera-
tionalized as the percentage of genes for which mothers
and children were concordant for the number of minor
alleles for each polymorphism. We then averaged the
concordance (e.g., percentage of the number of minor
alleles shared) across all 18 polymorphisms in order to
obtain an average percentage of minor alleles shared within
the portion of the xenobiotic pathway sampled here.
To create polygenic scores comprised of xenobiotic
metabolism genes, we used a k-fold cross validation
approach using a p threshold of 1, therefore including all
genes in the xenobiotic pathway regardless of significance
Table 1 Xenobiotic metabolism genes included in the present study
Family Function Gene rs#
N-
acetyltransferase
family
Codes an enzyme that is involved in the metabolism of drugs by
catalyzing the transfer of an acetyl group during the drug
metabolism process
N-acetyltransferase 1 (NAT1) rs4986782
rs4987076
Codes an enzyme that both activates and deactivates the
compounds catalyzed by the enzyme encoded by NAT1 as well
as carcinogens, and governs the speed of transferring acetyl
groups during drug metabolism (which is associated with drug
toxicity)
N-acetyltransferase 2 (NAT2) rs1799930
rs1799931
rs1801280
Glutathione
S-transferase
family
Plays important role in detoxification by coding for enzymes that
catalyze the conjugation of reduced glutathione with a variety of
hydrophobic and electrophilic compounds
Glutathione S-transferase pi 1
(GSTP1)
rs1695
Glutathione S-transferase mu 1
(GSTM1)
Deletion
Glutathione S-transferase theta 1
(GSTT1)
Deletion
Alcohol
dehydrogenase
family
Plays important role in the metabolism of a wide variety of drugs,
including alcohol
Alcohol dehydrogenase 7
(ADH7)
rs284779 intron
variant
Alcohol dehydrogenase 1A
(ADH1A)
rs975833 intron
variant
rs1229966 intron
variant 2 KB
upstream
rs2866151
Alcohol dehydrogenase 1B
(ADH1B)
s2066701 intron
variant
rs4147536 intron
variant
Alcohol dehydrogenase 4
(ADH4)
rs3762894 intron
variant 2 KB
upstream
rs4148884 intron
variant 2 KB
upstream
rs4699714 intron
variant
Cytochrome P450,
family 2,
subfamily A
Encodes cytochrome P450 proteins, which catalyze many
reactions involved in drug metabolism
Cytochrome P450, family 2,
subfamily A, polypeptide 6
(CYP2A6_9)
rs28399433
of the individual SNP. First, we split the participants ran-
domly into one of five (i.e., k = 5) folds. Then, inside of a
primary loop
1. We selected four folds as the discovery set and one
fold as the test set.
a.
Embedded in a second loop, we
i. mean centered each polymorphism,
ii. identified monomorphic polymorphisms, and
iii. ran a series of baseline regressions that
assessed the main effect of each individual
SNP on the outcome (described below) in the
discovery sample (comprised of 80 % of the
sample). Any monomorphic polymorphisms
identified in the specific training set were
given a beta-coefficient of 0 and p value of 1.
A. Maternal polymorphisms predicting SDP
(zero-inflated Poisson regression)
B. Child polymorphisms predicting SDP
(zero-inflated Poisson regression)
C. Child polymorphisms predicting birth
weight (linear regression)
D. Maternal polymorphisms predicting birth
weight (linear regression)
iv. From this series of baseline regressions (one
per polymorphism), we saved the coefficients.
This loop ran 18 times, equal to the number of
xenobiotic pathway polymorphisms available
in the data.
2. Next, (outside of the second loop but inside the
primary loop) we created a matrix of the genotypes in
the test sample after centering the genotypes in the test
matrix, and gave any missing values a value of 0 (equal
to the test sample average number of minor alleles for
that polymorphism). This is a mean imputation of
missing polymorphism information in the test sample.
3. Four polymorphisms in the alcohol dehydrogenase
family were in LD: rs1229966 with rs975833,
rs2066701, and (negatively) rs2866151; and rs975833
with rs2066701 for both mothers and children. There-
fore, we also pruned for LD (R2[ .70). For each pair
of SNPs in LD, we kept the coefficient and p-value of
the polymorphisms more highly associated with the
outcome, and set the coefficient to zero for the
polymorphisms more weakly associated with the
outcome so that it would not contribute to the
polygenic score.
4. Then, we multiplied the test matrix by the polymor-
phism coefficients to create our polygenic scores.
Specifically, the test matrix is 18 columns (for the 18
polymorphisms) by N rows (1 per individual). It gets
multiplied by a vector that is 18 values long (the 18
polymorphism weights from the training set). First,
each polymorphism weight is multiplied by each
individual’s corresponding polymorphism, and then
all the resulting values in that row (e.g., for that
individual) is summed. This results in a single value
for that individual’s weighted polygenic score.
5. Finally, we conducted a series of hypothesis-testing
regressions (described below). This primary loop was
repeated (k) times, so that each fold was the test set
once.
Thus, at the end of the primary loop (k) we had two
vectors for each regression analysis. There was a list of 5
(one for each loop (k), corresponding to each unique test
sample) coefficients from each regression assessing the
effect of the polygenic score on each outcome, and a list of
5 p-values for those coefficients. Consistency across these
results indicates a stable effect.
Within this framework, several regression analyses were
conducted. For models of smoking during pregnancy
(SDP), we used zero-inflated Poisson regressions to
account for the zero-inflated nature of SDP. For models of
child birth weight, linear regressions were used.
To assess criterion (b) relation of maternal genes and
SDP:
1. Maternal polygenic score conditioned on SDP (e.g.,
consisting of weighted coefficients from the models
where individual maternal polymorphisms predicted
SDP; A above), predicting SDP.
2. Maternal polygenic score conditioned on SDP (e.g.,
the same score as in regression 1) and a series of
potential confounding variables (child sex, maternal
educational attainment, social class, psychiatric prob-
lems, and age) added as covariates, predicting SDP.
To assess criterion (c) relation of child genes and SDP:
3. Child polygenic score conditioned on SDP (e.g.,
consisting of weighted coefficients from the models
where individual child polymorphisms predicted SDP;
B above) predicting SDP.
4. Child polygenic score conditioned on SDP (e.g., the
same score as in regression 3) and the potential
confounding variables predicting SDP.
To assess the baseline relation of genetic influence on
birth weight:
5. Child polygenic score conditioned on birth weight
(e.g., consisting of weighted coefficients from the
models where individual child polymorphisms pre-
dicted birth weight; C above) predicting child birth
weight
To assess criterion (d) relation of SDP and birth weight
accounting for child genetic influences:
6. Child polygenic score conditioned on birth weight
(e.g., the same score as in regression 5), SDP, and the
potential confounding variables, predicting child birth
weight.
We also examined the contribution of maternal genes on
birth weight for completeness:
7. Maternal polygenic score conditioned on birth weight
(e.g., consisting of weighted coefficients from the
models where individual maternal polymorphisms
predicted birth weight; D above), predicting child
birth weight
8. Maternal polygenic score conditioned on birth weight
(e.g., the same score as in regression 7), SDP, and the
potential confounding variables predicting SDP pre-
dicting child birth weight.
Results
We first assessed the percentage of polymorphisms for
which mothers and children were concordant for the
number of minor alleles in each of the 18 xenobiotic
metabolism genes. Across the 18 polymorphisms, mother
and child concordance was 57 % (statistically significantly
above the 50 % expected for mother- to- child transmis-
sion). Thus, the criterion (a) is met.
Results from the regression analyses within the K-fold
validation approach are summarized in Table 2. Neither
maternal nor child xenobiotic metabolism polygenic scores
were associated with a higher likelihood of smoking during
pregnancy, or to the severity of smoking during pregnancy
if SDP was endorsed. Thus, criteria (b) and (c) were not
met. SDP was associated with child birth weight. The zero-
order association in the full sample indicated that SDP was
associated with lower child birth weight (r = -.15,
unstandardized b = -37.30, p\ .0001). We examined
this association within the cross-validation approach in
order to test the association more conservatively. Even
controlling for the polygenic score (both maternal and
child) and maternal educational attainment, social class,
psychiatric problems, and age predicted child birth weight,
SDP was consistently (e.g., in each of the 5 folds) associ-
ated with lower birth weight. Neither the maternal nor child
xenobiotic metabolism polygenic score was directly asso-
ciated with child birth weight. Because criterion (b) and
(c) were not met, the data cannot support the passive rGE
or developmental GE cascade mechanism. We can only
conclude that SDP is consistently associated with birth
weight above and beyond other modeled maternal charac-
teristics and the influence of the polygenic contribution of
xenobiotic metabolism genes sampled here.
Discussion
We presented a theoretical method for disentangling
causal from non-causal joint effects of genetic and envi-
ronmental influences using molecular genetic data as a
way to corroborate findings from twin and family studies.
Empirically, we corroborated a very well-characterized
association of prenatal smoking exposure and low child
birth weight in a very large sample using a conservative
test—a k-fold cross-validation approach. The association
held consistently across folds even when controlling for
other maternal characteristics and a polygenic score rep-
resenting polymorphisms implicated in the xenobiotic
metabolism pathway. Our data did not meet the initial
criteria needed to separate these mechanisms. Nonethe-
less, we believe that our conceptual framework will be
useful for future studies harnessing molecular genetic data
to test findings from quantitative genetic designs. Cor-
roboration across study types and across quantitative and
molecular genetic study designs is imperative, as each
sample design comes with its own specific assumptions
and limitations.
Our findings potentially suggest that xenobiotic meta-
bolism genes are not likely contributing to the overlap in
genetic and SDP influences found in previous children-of-
twins and child-based twin studies. However, that conclu-
sion is tempered by the fact that the xenobiotic- or drug-
metabolizing pathways are highly complex, and we had
very limited coverage of the system with the 18 polymor-
phisms included in this study. We hope to explore these
questions using a more thorough examination including a
better sample of polymorphisms in the xenobiotic meta-
bolism pathway genes in the future. The limitation of our
insufficient coverage of a complex system is compounded
by the complexity of gene products, and that polymor-
phisms inherently measure gene structure, which is only
partly responsible for gene function. We summed the
effects of the polymorphisms into the weighted polygenic
score. A risk is that some polymorphisms have slightly
positive and others slightly negative effects on SDP. Thus,
when summed, some polymorphisms may wash the effects
of other out, and we are more likely to have a polygenic
score with null effects.2 Whereas this does limit our like-
lihood of finding a clear polygenic signal related to the
outcome, we believe that this most closely resembles the
underlying biology. Indeed, an individual likely has many
genes imparting risk and many others that act protectively
against the teratogenic effects of SDP, or of mothers’
ability to quit smoking. This may in part explain the null
findings for direct effects of xenobiotic metabolism genes on
SDP exposure and birth weight in this study. The field
examining polygenicity is very rapidly advancing, and as our
polygenic scoring methods improve, it will be worth revis-
iting the questions examined here to determine whether
methodological limitations led to the null findings for poly-
genic effects of xenobiotic metabolism genes on SDP.
Alternatively, xenobiotic metabolism pathway genes may
not be the relevant biological pathway for genetic influences
on SDP, or may be one of several pathways acting together.
Conceptual framework for passive rGE
and developmental genetic-environmental cascade
The most important contribution of this study is the theo-
retical framework for disentangling these important
mechanisms. We proposed a way to use molecular genetic
data to disentangle the inherently non-causal mechanism
(e.g., confounded with family background) of passive rGE
from a potentially causal (e.g., teratogenic) mechanism
whereby genetic and environmental influences unfold
temporally through biologically based mechanisms. Given
a set of underlying (fully testable) assumptions (Fig. 1a)
that mothers and children share the genetic variation of
interest, (Fig. 1b) that those maternal genetic variations are
related to the environmental exposure, and (Fig. 1c) that
child genetic variations are also related to the environ-
mental exposure (especially for passive rGE), one key
Table 2 Regression Results
Fold 1 b Fold 2 b Fold 3 b Fold 4 b Fold 5 b
Predicting the likelihood of not smoking during pregnancy (Inflated Zeros)
Maternal XMGV
Baseline 1.17 -0.56 0.68 0.08 -0.12
Controlled 2.29 -0.49 1.22 0.95 0.03
Child XMGV
Baseline -1.15 -0.96 -0.09 -0.96 -0.31
Controlled -2.61* -0.55 -0.19 -1.13 -0.23
Predicting SDP severity (Count, if SDP is present)
Maternal XMGV
Baseline -0.08 -0.02 -0.22 1.57 -0.10
Controlled -0.15 -0.54 -1.16 1.65 0.09
Child XMGV
Baseline 0.11 -0.50 -0.10 0.15 -0.42
Controlled -0.35 -0.47 -0.16 0.88 -0.68
Predicting Birth Weight
Main effects Only
Maternal XMGV 0.66 0.23 0.88 0.55 0.58
Child XMGV 0.03 0.63 0.56 0.39 -.31
SDP -35.23* -51.46* -46.27* -19.54* -35.31*
Controlled
Maternal XMGV 0.98 -0.14 -0.28 0.93 0.71
Child XMGV -0.06 0.54 0.34 0.15 -0.40
SDP controlling for covariates and maternal XMGV -21.46* -44.82* -57.17* -18.24* -39.46*
SDP controlling for covariates and child XMGV -22.51* -44.84* -57.16* -19.27* -39.59*
Covariates include child sex, maternal educational attainment, social class, psychiatric problems, and age
XMGV xenobiotic metabolism gene variants
* p\ .001
2 We also constructed scores using only the polymorphisms posi-
tively associated with conditioning variable in one score and the
polymorphisms negatively associated with the conditioning variable
in a separate score, and there were no differences in results
parameter (Fig. 1d) differentiates the two mechanisms. If
the association of the exposure and outcome is present
initially, but disappears when the polygenic score is added
to the model, then this is evidence of a specific passive
rGE. However, if the association is present and persists
when the maternal (Fig. 1, Gm) and child (Fig. 1, Gc)
polygenic scores are added to the model, then this is evi-
dence of a developmental GE cascade.
Thus far, quantitative genetic designs have been able to
investigate (e.g., children-of-twins) or control for (e.g.,
adoption, in vitro designs) passive rGE. A limitation of
quantitative genetic designs is that influences are neces-
sarily non-specific. Using polygenic scores (or other novel
methods) comprised of theoretically relevant gene sets can
help hone in on whether genetic and environmental influ-
ences work together for specific biologically based mech-
anism important for child development, or to understand
specific passive rGEs. Systems-based polygenic approa-
ches—when the system is adequately characterized—
should explain more variance in the phenotype than
broader molecular genetic approaches because a clear
effect (e.g., with less noise) related to the mechanism of
interest may be observed. However, this clear effect can
only explain the amount of the variance in the phenotype
that the specific mechanism under consideration actually
plays (not necessarily expected to be anywhere close to
100 %). It may become more difficult to find genetic
influences that play a meaningful role in the mechanism of
interest when the mechanism is insufficiently covered (e.g.,
only few relevant polymorphisms from only few relevant
genes are included) in the polygenic score. Further,
including phenotypes that are closer to the process (e.g.,
conditioning the polygenic score on a measure of efficiency
of drug metabolism) may increase the likelihood of
observing genetic influences that play a meaningful role in
the process of interest by cutting down the number of levels
the genetic influences need to operate across in order to
influence the phenotype. Thus, conditioning the polygenic
score on phenotypes as close to the biological mechanism
of interest and ensuring good coverage of both polymor-
phisms in each gene and relevant genes in the biological
system will increase the utility of this approach in future
work.
Other limitations and future directions
In addition to the limitations already discussed, there are a
number of other considerations important to keep in mind.
Including maternal and child genetic variation can help
elucidate causality in quantitative genetic designs (e.g., the
extended children of twins model; Narusyte et al. 2008).
However, as we move toward specificity of genetic (e.g.,
do not account for 100 % of the genetic variation) and
environmental influences to examine specific mechanisms
of interest (e.g., the role of xenobiotic metabolism genes
and SDP exposure for low birth weight), we no longer can
infer causality (e.g., using the conceptual framework pre-
sented here).
This is due to a number of limitations. First, it is prob-
able that related and confounding pathways exist, but are
not explicitly modeled, as is common in any study of
human behavior. The concepts of equifinality (the likeli-
hood that the same outcome is a downstream effect of
multiple possible temporally preceding influences) and
multifinality (the likelihood that a single developmental
influence can result in multiple outcomes through multiple
pathways; Cicchetti and Rogosch 1996) lead to predictions
that multiple biological pathways are likely to be impli-
cated in multiple outcomes. Specificity is very important to
understand these mechanisms, but is necessarily limited
because of how many important factors are necessarily
excluded from the model. Second, excluded genes are
highly likely to be associated with the genes included,
which diminishes our confidence that (especially small)
gene sets are causally linked to the exposure or outcome of
interest. Third, SDP was assessed via self-report and
therefore may be subject to error, for example, due to non-
disclosure. Future studies may do well to confirm SDP
exposure with cotinine levels, although self-report and
retrospective report have been shown to be valid in the
literature (e.g., Knopik et al. 2015b; Pickett et al. 2009;
Reich et al. 2003).
Further, there is a problem of correlated residual error
in the genetic influence whenever multiple genes are
examined together. This problem varies with the methods
used to examine joint effects of multiple genes. The
problem of correlated residual error in genotypes is
attenuated considerably by using genetic relatedness
matrixes in GCTA, but is generally unaccounted for when
using polygenic risk scores (thus far). Therefore, while the
framework presented here has the potential to disentangle
specific passive rGEs from plausibly causal biological
mechanisms, we stress that this framework does not infer
causality. Recent developments in using genome-wide
data have allowed for explicit tests of passive rGE using
an extended Genome-wide Complex Trait Analysis
(GCTA; Yang et al. 2011) approach incorporating both
maternal and child genome-wide data (m-GCTA; Eaves
et al. 2014). A strength of m-GCTA is that it maps quite
well onto quantitative genetic study designs, using similar
variance decomposition strategies and examining broad-
sense additive heritability. This approach has great
potential to disentangle causal environmental effects from
those confounded by maternal and child genes, and pas-
sive rGE in order to corroborate findings from quantitative
genetic models.
We continue to hope that examining variation from
multiple genes together will result in a stronger signal to
examine gene-environment interplay, and believe that
taking theoretically derived, systems-based approaches will
further augment our power for understanding when and
how genetic variation influences behavior in conjunction
with the environment. In terms of the present study, more
work is needed to understand whether the xenobiotic
metabolism pathway is actually unrelated to the smoking
during pregnancy- birth weight association because of the
limitations of the data used here. Further, we plan to vet the
current conceptual framework using simulated data in
order to further provide a proof of concept for the utility of
polygenic scores related to specific pathways to discover
when passive rGE plays a role versus when a GE cascade
may influence child development. As convergence across
multiple study designs with different limitations provides
the strongest evidence for gene-environment interplay, we
encourage the use of multiple ways of examining poly-
genicity and the continued use of both quantitative and
molecular genetic approaches.
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